Low dose azacitidine (AZA) reduces the incidence of chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) Meeting Abstract


Authors: de Lima, M.; Parmar, S.; Chen, J. J.; Giralt, S. A.; Rondon, G.; Popat, U. R.; Alousi, A. M.; Lee, H. C.; Woodworth, G. G.; Hosing, C. M.; Shpall, E. J.; Kebriaei, P.; Manero, G. G.; Champlin, R. E.; Saliba, R. M.
Abstract Title: Low dose azacitidine (AZA) reduces the incidence of chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)
Meeting Title: 54th Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 120
Issue: 21
Meeting Dates: 2012 Dec 8-11
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2012-11-01
Language: English
ACCESSION: WOS:000313838900217
PROVIDER: wos
DOI: 10.1182/blood.V120.21.742.742
Notes: --- - Meeting Abstract: 742 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1051 Giralt